longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Inhibrx Biosciences

INBX

101.7703.64% ( -3.840 )
Closed: Sep 16, 15:59:56 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -11.25, below the reasonable range, cheaper than 88.1% of the time in the past 5 years, and the industry ranks 461/601, the industry Median -2.44.

-11.25xP/E
$105.61Stock price
$-9.39Earnings per share
-11.25xP/E
Stock price$105.61Earnings per share$-9.39

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-6.62x
Typical range
-9.43x–0.09x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
019385776

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
GILDUSGilead Sciences
-55.99x148.77%$181.41B
CSLLYUSCSL Limited
-23.52x--$60.66B
MRNAUSModerna
-18.22x15.47%$57.40B
NTRAUSNatera
-262.87x10.38%$50.56B
RVMDUSRevolution Medicines
-24.83x64.29%$43.91B
ROIVUSRoivant Sciences
-107.16x148.13%$28.53B
INSMUSInsmed
-29.92x74.48%$26.19B
BNTXUSBioNTech SE
-12.41x19.17%$24.29B
SMMTUSSummit Therapeutics
-16.21x18.58%$13.88B
BBIOUSBridgebio Pharma
-19.32x28.57%$13.37B
MDGLUSMadrigal Pharma
-37.19x50.86%$12.09B
ARWRUSArrowHead Pharma
-31.20x36,308.30%$9.98B
CYTKUSCytokinetics
-10.78x6.37%$9.64B
KYMRUSKymera Therapeutics
-31.40x4.94%$9.41B
ABVXUSAbivax SA
-23.96x32.59%$9.30B
TWSTUSTwist Bioscience
-66.50x24.70%$9.09B
PCVXUSVaxcyte
-8.28x48.80%$8.81B
PRAXUSPraxis Precision Medicines
-25.76x3.05%$8.74B
IBRXUSImmunityBio
-8.69x152.63%$8.63B
SYREUSSpyre Therapeutics
-53.39x47.81%$8.02B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.